FIBROGEN INC — Director's Dealing 2022

Jan 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2022-01-06

Reporting Person: Conterno Enrique A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-06	Common Stock	F	1536	$13.93	Disposed	132704	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	27800	Indirect

Footnotes

F1: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.

F2: Includes one share acquired on November 15, 2021 through the Issuer's Employee Stock Purchase Plan.